Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-08T14:05:36.686Z Has data issue: false hasContentIssue false
  • English
  • Français

Persistence of antibody after subcutaneous vaccination with Wistar RA 27/3 rubella vaccine

Published online by Cambridge University Press:  15 May 2009

Irene B. Hillary
Irene B. Hillary
Affiliation:
Department of Medical Microbiology, University College, Dublin
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

After subcutaneous vaccination of rubella sero-negative children with Wistar RA 27/3 rubella vaccine, haemagglutination-inhibiting antibody titres were compared in sera taken 46 days and 2 years after vaccination. Antibody titres were well maintained in the absence of any known exposure to natural infection.

Type
Research Article
Information
Journal of Hygiene , Volume 69 , Issue 3 , September 1971 , pp. 369 - 372
Copyright
Copyright © Cambridge University Press 1971

References

REFERENCES

Buser, F., Nicholas, A. & Plotkin, S. A. (1969). Vaccination, with the RA 27/3 strain of attenuated rubella virus grown in human diploid cells. International Symposium on Rubella Vaccines, London 1968. Symposium Series on Immunological Standardisation, vol. xi, p. 391. Basle: Karger and Karger.Google Scholar
Hillary, I. B., Meenan, P. N., Griffith, A. H., Draper, C. C. & Laurence, G. (1969). Rubella vaccine trial in children. British Medical Journal ii, 531.CrossRefGoogle Scholar
Horstmann, D. M., Liebhaber, H., Le Bouvier, G. L., Rosenberg, D. A. & Halstead, S. B. (1970). Rubella reinfection of vaccinated and naturally immune persons. The New England Journal of Medicine 283, 771.CrossRefGoogle ScholarPubMed
Mann, J. J., Rossen, R. D., Lehrich, J. R. & Kasel, J. A. (1967). The effect of kaolin on immunoglobulins: an improved technique to remove the non-specific inhibitor of reovirus haemagglutination. Journal of Immunology 98, 1136.CrossRefGoogle Scholar
Meyer, H. M., Parkman, P. D., Hobbins, T. E., Larson, H. E., Davis, W. J., Simsarian, J. P. & Hopps, H. E. (1969). Attenuated rubella viruses. Laboratory and clinical characteristics. American Journal of Diseases of Children 118, 155.CrossRefGoogle ScholarPubMed
Phillips, C. A. & O'Brien, L. (1969). Thermostability of rubella haemagglutination inhibiting antibody. Applied Microbiology 17, 634.CrossRefGoogle Scholar
Plotkin, S. A., Bechtel, D. J. & Sedwick, W. D. (1968). A simple method for removal of rubella haemagglutination inhibitors from serum adaptable to finger tip blood. American Journal of Epidemiology 88, 301.CrossRefGoogle ScholarPubMed
Plotkin, S. A., Farquhar, J. D., Katz, M. & Hertz, C. (1969). Further studies of an attenuated rubella strain grown in WI-38 cells. American Journal of Epidemiology 89, 232.CrossRefGoogle ScholarPubMed
Prinzie, A., Huygelen, C., Gold, J., Farquhar, J. & McKee, J. (1969). Experimental live attenuated rubella virus vaccine. Clinical evaluation of Cendehill strain. American Journal of Diseases of Children 118, 172.CrossRefGoogle ScholarPubMed
Stewart, G. L., Parkman, P. D., Hopps, H. E., Douglas, R. D., Hamilton, J. P. & Meyer, H. M. (1967). Rubella virus haemagglutination – inhibition test. The New England Journal of Medicine 276, 554.CrossRefGoogle Scholar